Résumé
A pool of long synthetic peptides derived from HPV16 proteins induce objective partial or complete histologic regression of lesions in more than 50% of patients with high-grade vulvar (VuVIN3) and vaginal intraepithelial neoplasia (VaIN3). The intensity of T-cell response induced by the vaccine was correlated with clinical response.
langue originale | Anglais |
---|---|
Pages (de - à) | 2317-2319 |
Nombre de pages | 3 |
journal | Clinical Cancer Research |
Volume | 22 |
Numéro de publication | 10 |
Les DOIs | |
état | Publié - 15 mai 2016 |
Modification externe | Oui |